These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38606836)

  • 21. Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant
    Zasowski EJ; Trinh TD; Claeys KC; Lagnf AM; Bhatia S; Klinker KP; Veve MP; Estrada SJ; Johns ST; Sawyer AJ; Huang V; LaFrance B; Levine DP; Kaye KS; Davis SL; Rybak MJ
    Open Forum Infect Dis; 2022 Mar; 9(3):ofab606. PubMed ID: 35146040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjunctive ceftaroline in combination with daptomycin or vancomycin for complicated methicillin-resistant
    Hornak JP; Anjum S; Reynoso D
    Ther Adv Infect Dis; 2019; 6():2049936119886504. PubMed ID: 31857898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Kufel WD; Parsels KA; Blaine BE; Steele JM; Mahapatra R; Paolino KM; Thomas SJ
    Pharmacotherapy; 2023 Jan; 43(1):15-23. PubMed ID: 36371648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacodynamic comparison of different antimicrobial regimens against Staphylococcus aureus bloodstream infections with elevated vancomycin minimum inhibitory concentration.
    da Costa TM; Cuba GT; Morgado PGM; Nicolau DP; Nouér SA; Dos Santos KRN; Kiffer CRV
    BMC Infect Dis; 2020 Jan; 20(1):74. PubMed ID: 31973753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination Therapy With Vancomycin and Ceftaroline for Refractory Methicillin-resistant Staphylococcus aureus Bacteremia: A Case Series.
    Gritsenko D; Fedorenko M; Ruhe JJ; Altshuler J
    Clin Ther; 2017 Jan; 39(1):212-218. PubMed ID: 28038791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful Clearance of Persistent Methicillin-Resistant
    Shaddix G; Patel K; Simmons M; Burner K
    Case Rep Infect Dis; 2019; 2019():5623978. PubMed ID: 31281689
    [No Abstract]   [Full Text] [Related]  

  • 27. Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy.
    Ho TT; Cadena J; Childs LM; Gonzalez-Velez M; Lewis JS
    J Antimicrob Chemother; 2012 May; 67(5):1267-70. PubMed ID: 22311935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future.
    Bavaro DF; Belati A; Bussini L; Cento V; Diella L; Gatti M; Saracino A; Pea F; Viale P; Bartoletti M
    Expert Opin Drug Saf; 2024 Jan; 23(1):9-36. PubMed ID: 38145925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Update on Treatment Options for Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: A Systematic Review.
    Mahjabeen F; Saha U; Mostafa MN; Siddique F; Ahsan E; Fathma S; Tasnim A; Rahman T; Faruq R; Sakibuzzaman M; Dilnaz F; Ashraf A
    Cureus; 2022 Nov; 14(11):e31486. PubMed ID: 36523711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.
    Werth BJ; Barber KE; Ireland CE; Rybak MJ
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3177-81. PubMed ID: 24663016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches.
    Holubar M; Meng L; Alegria W; Deresinski S
    Infect Dis Clin North Am; 2020 Dec; 34(4):849-861. PubMed ID: 33011050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
    Mohan SS; McDermott BP; Cunha BA
    Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of fosfomycin alone and in combination against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid.
    Saravolatz LD; Pawlak J
    J Antimicrob Chemother; 2022 Dec; 78(1):238-241. PubMed ID: 36374572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study.
    Jorgensen SCJ; Zasowski EJ; Trinh TD; Lagnf AM; Bhatia S; Sabagha N; Abdul-Mutakabbir JC; Alosaimy S; Mynatt RP; Davis SL; Rybak MJ
    Clin Infect Dis; 2020 Jun; 71(1):1-10. PubMed ID: 31404468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible Staphylococcus aureus during therapy improves antibacterial activity.
    Rose WE; Schulz LT; Andes D; Striker R; Berti AD; Hutson PR; Shukla SK
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5296-302. PubMed ID: 22869564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study.
    Kalimuddin S; Chan YFZ; Phillips R; Ong SP; Archuleta S; Lye DC; Tan TT; Low JGH
    Trials; 2018 Jun; 19(1):305. PubMed ID: 29859132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model.
    Werth BJ; Sakoulas G; Rose WE; Pogliano J; Tewhey R; Rybak MJ
    Antimicrob Agents Chemother; 2013 Jan; 57(1):66-73. PubMed ID: 23070161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effectiveness of daptomycin versus vancomycin among patients with methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: A systematic literature review and meta-analysis.
    Adamu Y; Puig-Asensio M; Dabo B; Schweizer ML
    PLoS One; 2024; 19(2):e0293423. PubMed ID: 38381737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of ceftaroline in combination with other antimicrobials active against Staphylococcus spp.
    Gil Romero Y; Gómez-Garcés JL
    Enferm Infecc Microbiol Clin (Engl Ed); 2020 Jan; 38(1):25-27. PubMed ID: 31072712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment with daptomycin and ceftaroline of MDR Staphylococcus aureus native valve endocarditis: a case report.
    Duss FR; Garcia de la Mària C; Croxatto A; Giulieri S; Lamoth F; Manuel O; Miró JM
    J Antimicrob Chemother; 2019 Sep; 74(9):2626-2630. PubMed ID: 31298264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.